A Veronica Araya1, Ximena Orellana, Jaime Espinoza. 1. Endocrinology Section, Department of Internal Medicine, University of Chile Clinical Hospital, Santos Dumont 999, Independencia, Santiago, Chile. varaya@redclinicauchile.cl
Abstract
UNLABELLED: Brain-derived neurotrophic factor (BDNF) has emerged as a new element related with insulin resistance and obesity. OBJECTIVE: To evaluate the effect of a 3-month reduced-calorie diet (RCD) on serum BDNF concentrations in overweight and obese subjects. SUBJECTS: Seventeen healthy overweight and obese subjects of both sexes (24 - 48 years, BMI 34.6 +/- 1.1 kg/m2). METHODS: Anthropometry, oral glucose tolerance test (OGTT), lipid levels, and serum BDNF were measured at baseline and at the end of the third month. Reduced-calorie diet was defined as a 25% reduction in energy intake composed of: 55% carbohydrates, 20% proteins, and 25% fat (less than 10% saturated fat and over 10% nonsaturated fat). Refined sugar was not allowed. RESULTS: There was a significant decrease in BMI, waist circumference, body fat percentage, fasting glucose, post-OGTT glucose levels, area under the curve of glucose, and HOMA2-IR after 3 months of RCD. Serum BDNF showed a significant increase (3.97 +/- 0.87 to 6.75 +/- 1.62 ng/ml, P = 0.02). Final serum BDNF correlated negatively with weight (r = -0.51, P = 0.03), and basal post-OGTT insulin correlated positively with final serum BDNF (r = 0.48, P = 0.04). CONCLUSIONS: Serum BDNF increases in insulin-resistant overweight and obese subjects after three months on a RCD. This observation could indicate that BDNF may be modulated in humans through diet composition.
UNLABELLED: Brain-derived neurotrophic factor (BDNF) has emerged as a new element related with insulin resistance and obesity. OBJECTIVE: To evaluate the effect of a 3-month reduced-calorie diet (RCD) on serum BDNF concentrations in overweight and obese subjects. SUBJECTS: Seventeen healthy overweight and obese subjects of both sexes (24 - 48 years, BMI 34.6 +/- 1.1 kg/m2). METHODS: Anthropometry, oral glucose tolerance test (OGTT), lipid levels, and serum BDNF were measured at baseline and at the end of the third month. Reduced-calorie diet was defined as a 25% reduction in energy intake composed of: 55% carbohydrates, 20% proteins, and 25% fat (less than 10% saturated fat and over 10% nonsaturated fat). Refined sugar was not allowed. RESULTS: There was a significant decrease in BMI, waist circumference, body fat percentage, fasting glucose, post-OGTT glucose levels, area under the curve of glucose, and HOMA2-IR after 3 months of RCD. Serum BDNF showed a significant increase (3.97 +/- 0.87 to 6.75 +/- 1.62 ng/ml, P = 0.02). Final serum BDNF correlated negatively with weight (r = -0.51, P = 0.03), and basal post-OGTT insulin correlated positively with final serum BDNF (r = 0.48, P = 0.04). CONCLUSIONS: Serum BDNF increases in insulin-resistant overweight and obese subjects after three months on a RCD. This observation could indicate that BDNF may be modulated in humans through diet composition.
Authors: Navin Maswood; Jennifer Young; Edward Tilmont; Zhiming Zhang; Don M Gash; Greg A Gerhardt; Richard Grondin; George S Roth; Julie Mattison; Mark A Lane; Richard E Carson; Robert M Cohen; Peter R Mouton; Christopher Quigley; Mark P Mattson; Donald K Ingram Journal: Proc Natl Acad Sci U S A Date: 2004-12-16 Impact factor: 11.205
Authors: Baoji Xu; Evan H Goulding; Keling Zang; David Cepoi; Roger D Cone; Kevin R Jones; Laurence H Tecott; Louis F Reichardt Journal: Nat Neurosci Date: 2003-07 Impact factor: 24.884
Authors: Palmiero Monteleone; Alfonso Tortorella; Vassilis Martiadis; Cristina Serritella; Antonio Fuschino; Mario Maj Journal: Psychosom Med Date: 2004 Sep-Oct Impact factor: 4.312
Authors: A Tsuchida; T Nonomura; T Nakagawa; Y Itakura; M Ono-Kishino; M Yamanaka; E Sugaru; M Taiji; H Noguchi Journal: Diabetes Obes Metab Date: 2002-07 Impact factor: 6.577
Authors: Na Yang; Elizabeth Levey; Bizu Gelaye; Qiu-Yue Zhong; Marta B Rondon; Sixto E Sanchez; Michelle A Williams Journal: Arch Womens Ment Health Date: 2017-07-27 Impact factor: 3.633
Authors: M N Harvie; M Pegington; M P Mattson; J Frystyk; B Dillon; G Evans; J Cuzick; S A Jebb; B Martin; R G Cutler; T G Son; S Maudsley; O D Carlson; J M Egan; A Flyvbjerg; A Howell Journal: Int J Obes (Lond) Date: 2010-10-05 Impact factor: 5.095